A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C
- 16 July 2002
- journal article
- clinical trial
- Published by Springer Nature in The Hematology Journal
- Vol. 3 (3) , 131-136
- https://doi.org/10.1038/sj.thj.6200165
Abstract
Nature - the world's best science and medicine on your desktopKeywords
This publication has 0 references indexed in Scilit: